Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

ESMO

- PMLiVE

Finalists decided in UK cancer awards

QiC Excellence in Oncology aims to recognise good practice in cancer care throughout UK

EACCME to announce new accreditation guidelines at forthcoming CME Forum

The announcement will coincide with the gCMEp’s celebration of their own peer review publication of their own guidelines 

- PMLiVE

Merck KGaA acquires cancer drug from Symphogen

Will pay up to €495m for investigational metastatic colorectal cancer treatment

- PMLiVE

Closing the clinical practice gap

Education has evolved to use rich and diverse approaches to close the well-reported gap between evidence and practice

Roche - Basel

Roche says pipeline will balance cancer drug patent losses

Has 11 new molecular entities in late-stage portfolio and 11 line extensions

INC Research promotes Susan Akers-Smith to senior oncology role

She takes up the position of VP of early phase oncology development

- PMLiVE

IFPMA launches expanded code of practice

Clarifies guidelines on continuing medical education and gifts for doctors

- PMLiVE

The value of multi-disciplinary external expert collaboration

Well-planned collaborations result in productive and sustainable programmes

Astellas wins US approval for prostate cancer drug Xtandi

Pharma company and its partner Medivation gain FDA licence for type of late-stage prostate cancer

- PMLiVE

J&J signs $1.1bn deal with Genmab for cancer antibody

Licenses daratumumab in development for multiple myeloma

- PMLiVE

Antibody-drug conjugates on the up in cancer

Mylotarg served as a lesson of the pitfalls of ADCs: two years after it was pulled from the market some of the ADCs now in development will emerge as blockbusters

- PMLiVE

Pfizer dealt another blow as Torisel fails kidney cancer trial

Results are another setback in company's bid to extend the indications for its mTOR inhibitor

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links